🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested
This open label randomized study will be conducted to evaluate and/or descr...
Status
Completed
Location
Investigational Site Number : 3560006
Start Date
2023-03-27
Trial ID
NCT05794230
Treatments Being Tested
To further characterize the safety profile of Menactra vaccine and to ident...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00254995
Treatments Being Tested
This study will be a randomized observer -blinded controlled non-inferiorit...
Status
Completed
Location
Mohiul Islam Chowdhury
Start Date
2017-08-21
Trial ID
NCT03263403
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00355121
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
Primary objectives: * To describe the antibody responses to meningococcal ...
Status
Completed
Location
Multiple Locations
Start Date
2012-11-12
Trial ID
NCT01732627